Prognia
Drug Database
🇪🇺EU · EMAWithdrawnATC: D03AX13

Episalvan(Betulae cortex)

Wounds and Injuries;Wound Healing

Marketing Authorisation Holder: Amryt AG

EMA Authorisation: 14/01/2016

INN: birch bark extract

Indication

Treatment of partial thickness wounds in adults. See sections 4.4 and 5.1 in Product Information with respect to type of wounds studied.

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about Episalvan — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.